Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
Clinical trial NCT03780959 · COMPLETED
Trial details
- NCT number
- NCT03780959
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1997-05-01
- Primary completion
- 1998-07-08
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.